Pfizer’s Ian Read looks to count Allergan merger as his legacy - FT.com
Pfizer’s Ian Read looks to count Allergan merger as his legacy - FT.com
ft.comFor Ian Read, Pfizer’s $160bn tie-up with Allergan announced this week marked the end of a two-year search for